Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816)

Cancer Chemother Rep. 1974 Mar-Apr;58(2):217-22.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Azacitidine / administration & dosage*
  • Azacitidine / adverse effects
  • Azacitidine / blood
  • Azacitidine / therapeutic use
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Drug Evaluation
  • Female
  • Hepatic Encephalopathy / chemically induced
  • Humans
  • Injections, Subcutaneous
  • Leukocyte Count
  • Male
  • Middle Aged
  • Neoplasms / drug therapy
  • Remission, Spontaneous

Substances

  • Azacitidine